213 related articles for article (PubMed ID: 35112886)
21. Left Ventricular Hypertrophy and Biomarkers of Cardiac Damage and Stress in Aortic Stenosis.
Stein EJ; Fearon WF; Elmariah S; Kim JB; Kapadia S; Kumbhani DJ; Gillam L; Whisenant B; Quader N; Zajarias A; Welt FG; Bavry AA; Coylewright M; Piana RN; Mallugari RR; Clark DE; Patel JN; Gonzales H; Gupta DK; Vatterott A; Jackson N; Huang S; Lindman BR
J Am Heart Assoc; 2022 Apr; 11(7):e023466. PubMed ID: 35301869
[TBL] [Abstract][Full Text] [Related]
22. Absence of electrocardiographic left ventricular hypertrophy and poor outcome in patients undergoing transcatheter aortic valve replacement-A systematic review and meta-analysis.
Martha JW; Pranata R; Yonas E; Wibowo A; Akbar MR
J Card Surg; 2021 Jul; 36(7):2233-2239. PubMed ID: 33768590
[TBL] [Abstract][Full Text] [Related]
23. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations.
Lindman BR; Stewart WJ; Pibarot P; Hahn RT; Otto CM; Xu K; Devereux RB; Weissman NJ; Enriquez-Sarano M; Szeto WY; Makkar R; Miller DC; Lerakis S; Kapadia S; Bowers B; Greason KL; McAndrew TC; Lei Y; Leon MB; Douglas PS
JACC Cardiovasc Interv; 2014 Jun; 7(6):662-73. PubMed ID: 24947722
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Araoye's criteria with standard electrocardiographic criteria for diagnosis of left ventricular hypertrophy in Nigerian hypertensives.
Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
West Afr J Med; 2006; 25(3):179-85. PubMed ID: 17191415
[TBL] [Abstract][Full Text] [Related]
25. Regression of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation for Aortic Stenosis.
Tobe A; Tanaka A; Tokuda Y; Akita S; Fujii T; Miki Y; Furusawa K; Ishii H; Usui A; Murohara T
Circ J; 2021 Jun; 85(7):1093-1098. PubMed ID: 34039838
[TBL] [Abstract][Full Text] [Related]
26. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
[TBL] [Abstract][Full Text] [Related]
27. The decrease in QRS amplitude after aortic valve replacement in patients with aortic valve stenosis.
Kurisu S; Inoue I; Kawagoe T; Ishihara M; Shimatani Y; Nakama Y; Maruhashi T; Kagawa E; Dai K; Matsushita J; Ikenaga H
J Electrocardiol; 2009; 42(5):410-3. PubMed ID: 19368931
[TBL] [Abstract][Full Text] [Related]
28. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
Porthan K; Kenttä T; Niiranen TJ; Nieminen MS; Oikarinen L; Viitasalo M; Hernesniemi J; Jula AM; Salomaa V; Huikuri HV; Albert CM; Tikkanen JT
Int J Cardiol; 2019 Feb; 276():125-129. PubMed ID: 30293667
[TBL] [Abstract][Full Text] [Related]
29. Performance of electrocardiographic criteria for left ventricular hypertrophy as compared with cardiac computed tomography: from the Rule Out Myocardial Infarction Using Computer Assisted Tomography trial.
Truong QA; Ptaszek LM; Charipar EM; Taylor C; Fontes JD; Kriegel M; Irlbeck T; Toepker M; Schlett CL; Bamberg F; Blankstein R; Brady TJ; Nagurney JT; Hoffmann U
J Hypertens; 2010 Sep; 28(9):1959-67. PubMed ID: 20498615
[TBL] [Abstract][Full Text] [Related]
30. Gender differences in factors influencing electrocardiographic findings of left ventricular hypertrophy in severe aortic stenosis.
Satoh S; Omura S; Inoue H; Ejima E; Shimozono K; Hayashi M; Mori T; Takenaka K; Kawamura N; Numaguchi K; Mori E; Asoh A; Nakamura T; Hiyamuta K
Heart Vessels; 2014 Sep; 29(5):659-66. PubMed ID: 23979264
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of body mass index-adjusted criteria for left ventricular hypertrophy.
Afify H; Lee HL; Soliman EZ; Singleton MJ
J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1476-1483. PubMed ID: 32762125
[TBL] [Abstract][Full Text] [Related]
32. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
[TBL] [Abstract][Full Text] [Related]
33. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
[TBL] [Abstract][Full Text] [Related]
34. The Use of Romhilt-Estes Criteria in the Presumptive Electrocardiographic Diagnosis of Left Ventricular Hypertrophy in Comparison to Voltage-Based Criteria.
Hamed M; Dasari G; Casale JA; Kaur N; Karl M
Cureus; 2022 Aug; 14(8):e28003. PubMed ID: 36134101
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of ECG criteria for the diagnosis of left ventricular hypertrophy: a comparison with magnetic resonance imaging.
Krittayaphong R; Nomsawadi V; Muenkaew M; Miniphan M; Yindeengam A; Udompunturak S
J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S124-32. PubMed ID: 23590032
[TBL] [Abstract][Full Text] [Related]
36. Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.
Chau KH; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
J Am Coll Cardiol; 2020 May; 75(19):2446-2458. PubMed ID: 32408979
[TBL] [Abstract][Full Text] [Related]
37. Correlation between Echocardiographic Left Ventricular Hypertrophy and various Electrocardiographic Criteria of Left Ventricular Hypertrophy among Black Hypertensives.
Ngabea MA; Ojji DB; Sani MU; Isezuo SA
West Afr J Med; 2021 Jul; 38(7):695-700. PubMed ID: 34331528
[TBL] [Abstract][Full Text] [Related]
38. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
[TBL] [Abstract][Full Text] [Related]
39. Obesity and ECG left ventricular hypertrophy.
Muiesan ML; Salvetti M; Di Castelnuovo A; Paini A; Assanelli D; Costanzo S; Badilini F; Vaglio M; Donati MB; Agabiti Rosei E; de Gaetano G; Iacoviello L;
J Hypertens; 2017 Jan; 35(1):162-169. PubMed ID: 27662187
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
